Scinai Immunotherapeutics (SCNI) Change in Account Payables (2019 - 2026)
Scinai Immunotherapeutics (SCNI) reported Change in Account Payables of $199000.0 for Q1 2026, up 17.75% on a YoY basis from $169000.0 in Q1 2025, and up 74.56% sequentially from $114000.0 in Q2 2025.
Scinai Immunotherapeutics (SCNI) Change in Account Payables (2019 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 8 years of Change in Account Payables data on file, last reported at $199000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 17.75% year-over-year to $199000.0; the trailing twelve-month figure through Mar 2026 stood at $428000.0 (up 244.59% YoY), and the FY2025 full-year result was -$157000.0, down 0.64% from the prior year.
- Change in Account Payables advanced to $199000.0 in Q1 2026, from $114000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $889000.0 in Q4 2022 to a low of -$660000.0 in Q2 2023.
- A 5-year average of $32333.3 and a median of -$15000.0 in 2023 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables soared 696.2% in 2023 and slumped 260.0% in 2024, its largest moves.
- Tracing SCNI's Change in Account Payables over 5 years: stood at $889000.0 in 2022, then slumped by 101.69% to -$15000.0 in 2023, then tumbled by 260.0% to -$54000.0 in 2024, then jumped by 311.11% to $114000.0 in 2025, then surged by 74.56% to $199000.0 in 2026.
- Business Quant data shows SCNI's Change in Account Payables at $199000.0 in Q1 2026, $114000.0 in Q2 2025, and $169000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | 16.86 Mn |
| 10 | Scinai Immunotherapeutics | 3.72 Bn | 604.39 Mn | -1.12 Mn | 199,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 199,000.00 |
| Mar 31, 2026 | 199,000.00 |
| Jun 30, 2025 | 114,000.00 |
| Jun 30, 2025 | 114,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Dec 31, 2024 | -54,000.00 |
| Dec 31, 2024 | -54,000.00 |
| Sep 30, 2024 | -227,000.00 |
| Sep 30, 2024 | -227,000.00 |
| Jun 30, 2024 | -184,000.00 |
| Jun 30, 2024 | -184,000.00 |
| Mar 31, 2024 | 309,000.00 |
| Mar 31, 2024 | 309,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Sep 30, 2023 | -104,000.00 |
| Sep 30, 2023 | -104,000.00 |
| Jun 30, 2023 | -660,000.00 |
| Jun 30, 2023 | -660,000.00 |